Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report

Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common background genetic or environmental factors. This study presents development of rheumatoid arthritis (RA) during treatment of MS. The MS was confirmed by the Mc Donald criteria and the diagnosis of RA...

Full description

Saved in:
Bibliographic Details
Published in:Journal of advanced research 2016-09, Vol.7 (5), p.611-613
Main Authors: Hojjati, Seyed Mohammad Masood, Heidari, Behzad, Babaei, Mansour
Format: Article
Language:English
Subjects:
Case Report
Coexistence
Interferon beta 1-a
Multiple sclerosis
Rheumatoid arthritis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413
cites cdi_FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413
container_end_page 613
container_issue 5
container_start_page 611
container_title Journal of advanced research
container_volume 7
creator Hojjati, Seyed Mohammad Masood
Heidari, Behzad
Babaei, Mansour
description Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common background genetic or environmental factors. This study presents development of rheumatoid arthritis (RA) during treatment of MS. The MS was confirmed by the Mc Donald criteria and the diagnosis of RA was confirmed by the ACR/EULAR criteria. A 35years old women with 9years of MS who was receiving interferon beta 1-a (INF) for 7years and who did not respond to conventional therapy of RA over 8months developed clinical manifestations of RA. But a rapid response was observed after discontinuation of INF. These findings suggest a possible contribution of INF in the development of RA.
doi_str_mv 10.1016/j.jare.2016.06.004
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7ec0f082d245453dbc8f51a0df55c27a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2090123216300431</els_id><doaj_id>oai_doaj_org_article_7ec0f082d245453dbc8f51a0df55c27a</doaj_id><sourcerecordid>S2090123216300431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413</originalsourceid><addsrcrecordid>eNp9Uttq3DAQNaWlCWl-oA9FP2BHkiVbLqUQtk0bCPSlfRZjabwrY1tG1m7IX_UTK2e7S_NSMaDR6JwzzCXL3jNaMMqqm77oIWDBk1_QZFS8yi45bWjOOBevz37JL7LrZelpOqVSDWNvswteC9XUvL7Mfn_BAw5-HnGKxHck7HA_QvTOEghxF1x0C7H74KYtiQEhnoDjfohuHpAsZsDglwR7dHFH3BQxdCkykRYjEJZDQTbeTcZZnAyu3PjoifGTTeJ-WogPBNJ7nAdnYA09Y07JPpJbYmBBEnD2Ib7L3nQwLHj9977Kft19_bn5nj_8-Ha_uX3IjVAq5hwrwblVBstGdB1WrURJlQXJhARR1lZIjsAtlIrSpmIgZdnK2kDV1qVg5VV2f9S1Hno9BzdCeNIenH4O-LDVqUEuFa9rNLSjilsupJClbY3qJANqOykNryFpfT5qzft2RGtSVQGGF6Ivfya301t_0KKRlDGVBPhRwKROLwG7M5dRva6D7vW6DnpdB02TUZFIH_7Neqachp8An44ATH08OAx6MW6dkXUBTUyFuv_p_wHhyMtj</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report</title><source>ScienceDirect Additional Titles</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Hojjati, Seyed Mohammad Masood ; Heidari, Behzad ; Babaei, Mansour</creator><creatorcontrib>Hojjati, Seyed Mohammad Masood ; Heidari, Behzad ; Babaei, Mansour</creatorcontrib><description>Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common background genetic or environmental factors. This study presents development of rheumatoid arthritis (RA) during treatment of MS. The MS was confirmed by the Mc Donald criteria and the diagnosis of RA was confirmed by the ACR/EULAR criteria. A 35years old women with 9years of MS who was receiving interferon beta 1-a (INF) for 7years and who did not respond to conventional therapy of RA over 8months developed clinical manifestations of RA. But a rapid response was observed after discontinuation of INF. These findings suggest a possible contribution of INF in the development of RA.</description><identifier>ISSN: 2090-1232</identifier><identifier>EISSN: 2090-1224</identifier><identifier>DOI: 10.1016/j.jare.2016.06.004</identifier><identifier>PMID: 27489727</identifier><language>eng</language><publisher>Egypt: Elsevier B.V</publisher><subject>Case Report ; Coexistence ; Interferon beta 1-a ; Multiple sclerosis ; Rheumatoid arthritis</subject><ispartof>Journal of advanced research, 2016-09, Vol.7 (5), p.611-613</ispartof><rights>2016</rights><rights>2016 Production and hosting by Elsevier B.V. on behalf of Cairo University. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413</citedby><cites>FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950118/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2090123216300431$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3536,27901,27902,45756,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27489727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hojjati, Seyed Mohammad Masood</creatorcontrib><creatorcontrib>Heidari, Behzad</creatorcontrib><creatorcontrib>Babaei, Mansour</creatorcontrib><title>Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report</title><title>Journal of advanced research</title><addtitle>J Adv Res</addtitle><description>Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common background genetic or environmental factors. This study presents development of rheumatoid arthritis (RA) during treatment of MS. The MS was confirmed by the Mc Donald criteria and the diagnosis of RA was confirmed by the ACR/EULAR criteria. A 35years old women with 9years of MS who was receiving interferon beta 1-a (INF) for 7years and who did not respond to conventional therapy of RA over 8months developed clinical manifestations of RA. But a rapid response was observed after discontinuation of INF. These findings suggest a possible contribution of INF in the development of RA.</description><subject>Case Report</subject><subject>Coexistence</subject><subject>Interferon beta 1-a</subject><subject>Multiple sclerosis</subject><subject>Rheumatoid arthritis</subject><issn>2090-1232</issn><issn>2090-1224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9Uttq3DAQNaWlCWl-oA9FP2BHkiVbLqUQtk0bCPSlfRZjabwrY1tG1m7IX_UTK2e7S_NSMaDR6JwzzCXL3jNaMMqqm77oIWDBk1_QZFS8yi45bWjOOBevz37JL7LrZelpOqVSDWNvswteC9XUvL7Mfn_BAw5-HnGKxHck7HA_QvTOEghxF1x0C7H74KYtiQEhnoDjfohuHpAsZsDglwR7dHFH3BQxdCkykRYjEJZDQTbeTcZZnAyu3PjoifGTTeJ-WogPBNJ7nAdnYA09Y07JPpJbYmBBEnD2Ib7L3nQwLHj9977Kft19_bn5nj_8-Ha_uX3IjVAq5hwrwblVBstGdB1WrURJlQXJhARR1lZIjsAtlIrSpmIgZdnK2kDV1qVg5VV2f9S1Hno9BzdCeNIenH4O-LDVqUEuFa9rNLSjilsupJClbY3qJANqOykNryFpfT5qzft2RGtSVQGGF6Ivfya301t_0KKRlDGVBPhRwKROLwG7M5dRva6D7vW6DnpdB02TUZFIH_7Neqachp8An44ATH08OAx6MW6dkXUBTUyFuv_p_wHhyMtj</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Hojjati, Seyed Mohammad Masood</creator><creator>Heidari, Behzad</creator><creator>Babaei, Mansour</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160901</creationdate><title>Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report</title><author>Hojjati, Seyed Mohammad Masood ; Heidari, Behzad ; Babaei, Mansour</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Case Report</topic><topic>Coexistence</topic><topic>Interferon beta 1-a</topic><topic>Multiple sclerosis</topic><topic>Rheumatoid arthritis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hojjati, Seyed Mohammad Masood</creatorcontrib><creatorcontrib>Heidari, Behzad</creatorcontrib><creatorcontrib>Babaei, Mansour</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of advanced research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hojjati, Seyed Mohammad Masood</au><au>Heidari, Behzad</au><au>Babaei, Mansour</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report</atitle><jtitle>Journal of advanced research</jtitle><addtitle>J Adv Res</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>7</volume><issue>5</issue><spage>611</spage><epage>613</epage><pages>611-613</pages><issn>2090-1232</issn><eissn>2090-1224</eissn><abstract>Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common background genetic or environmental factors. This study presents development of rheumatoid arthritis (RA) during treatment of MS. The MS was confirmed by the Mc Donald criteria and the diagnosis of RA was confirmed by the ACR/EULAR criteria. A 35years old women with 9years of MS who was receiving interferon beta 1-a (INF) for 7years and who did not respond to conventional therapy of RA over 8months developed clinical manifestations of RA. But a rapid response was observed after discontinuation of INF. These findings suggest a possible contribution of INF in the development of RA.</abstract><cop>Egypt</cop><pub>Elsevier B.V</pub><pmid>27489727</pmid><doi>10.1016/j.jare.2016.06.004</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-1232
ispartof Journal of advanced research, 2016-09, Vol.7 (5), p.611-613
issn 2090-1232
2090-1224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7ec0f082d245453dbc8f51a0df55c27a
source ScienceDirect Additional Titles; IngentaConnect Journals; PubMed Central
subjects Case Report
Coexistence
Interferon beta 1-a
Multiple sclerosis
Rheumatoid arthritis
title Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T19%3A55%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20rheumatoid%20arthritis%20during%20treatment%20of%20multiple%20sclerosis%20with%20interferon%20beta%201-a.%20Coincidence%20of%20two%20conditions%20or%20a%20complication%20of%20treatment:%20A%20case%20report&rft.jtitle=Journal%20of%20advanced%20research&rft.au=Hojjati,%20Seyed%20Mohammad%20Masood&rft.date=2016-09-01&rft.volume=7&rft.issue=5&rft.spage=611&rft.epage=613&rft.pages=611-613&rft.issn=2090-1232&rft.eissn=2090-1224&rft_id=info:doi/10.1016/j.jare.2016.06.004&rft_dat=%3Celsevier_doaj_%3ES2090123216300431%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c488t-2e6422d8ce394ffe6b5e508da5145a437d452ea2da3800961a553b57ca6b73413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27489727&rfr_iscdi=true